ArticleBone marrow transplantation2020

Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.

Sujith DhanasiriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.